Inventor · Salisbury, GB

Patrick Stancombe

20Patents

8h-index

16Co-inventors

68Inventor score

Filing activity: Sep 12, 2002 → Feb 22, 2013

Most-cited inventions

Patent	Title	Area	Cited by	Status
US7192596B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	81	Expired
US7659092B2	Fusion proteins	Chemistry; Metallurgy	31	Active
US8067200B2	Fusion proteins	Chemistry; Metallurgy	29	Active
US8399401B2	Fusion proteins	Chemistry; Metallurgy	12	Active
US9243301B2	Fusion proteins	Chemistry; Metallurgy	10	Active
US8124074B2	Fusion proteins	Chemistry; Metallurgy	10	Active
US8399400B2	Fusion proteins	Chemistry; Metallurgy	9	Active
US8940870B2	Fusion proteins	Chemistry; Metallurgy	8	Active
US9072736B2	Treatment of pain	Chemistry; Metallurgy	6	Active
US7674470B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	6	Active
US8372615B2	Fusion proteins	Chemistry; Metallurgy	5	Active
US7897158B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	5	Active
US8124405B2	Fusion proteins	Chemistry; Metallurgy	4	Active
US8012491B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	3	Active
US8614069B2	Non-cytotoxic fusion proteins comprising EGF muteins	Chemistry; Metallurgy	3	Active
US8956847B2	Fusion proteins	Chemistry; Metallurgy	3	Active
US8017134B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	2	Active
US8454976B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	2	Active
US8012479B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	2	Active
US9006395B2	Recombinant toxin fragments	Emerging Cross-Sectional Technologies	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.